Related Experiment Videos
Functional loss of tumour suppressor genes in multistage chemical carcinogenesis
Abstract:
Studies of multistage carcinogenesis in mouse skin have provided many of the early concepts of tumour initiation, promotion and progression. Genetic approaches have led to the identification of a number of mutational alterations in proto-oncogenes and tumour suppressor genes which take place at specific stages of carcinogenesis in this particular system. Initiation involves, at least in a proportion of tumours, mutational activation of the cellular H-ras proto-oncogene. Trisomy of chromosome 7, which develops during the premalignant clonal expansion phase, possibly as a consequence of tumour promoter treatment, is followed by further alterations on chromosome 7 which lead to a relative increase in the expression of mutant ras alleles. The p53 tumour suppressor gene undergoes mutational alteration and loss of heterozygosity in a proportion of squamous carcinomas but this particular gene does not appear to be involved in the further transition of squamous carcinomas to highly undifferentiated spindle cell tumours. The latter transition appears to be a recessive event which can be complemented by fusion with cells at earlier stages of malignancy. Mouse skin carcinogenesis therefore continues to provide invaluable information on the nature of the genetic and biological transitions which occur during the step-wise progression of normal cells to malignancy.
Insights
Mouse skin cancer studies reveal key genetic changes in tumor development. Researchers identified specific gene mutations and chromosomal alterations driving tumor initiation, progression, and undifferentiated cell transitions.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Multistage carcinogenesis research in mouse skin established foundational concepts of tumor initiation, promotion, and progression.
- Genetic studies have identified specific mutational alterations in proto-oncogenes and tumor suppressor genes crucial to carcinogenesis.
Purpose of the Study:
- To elucidate the genetic and biological transitions occurring during the stepwise progression of normal cells to malignancy in mouse skin.
- To identify specific genetic alterations, including proto-oncogene mutations and chromosomal changes, associated with different stages of carcinogenesis.
Main Methods:
- Utilized genetic approaches to identify mutational alterations in proto-oncogenes and tumor suppressor genes.
- Analyzed chromosomal changes, such as trisomy of chromosome 7, during premalignant clonal expansion.
- Investigated the role of the p53 tumor suppressor gene in squamous carcinoma progression.
Main Results:
- Tumor initiation involves, in part, mutational activation of the cellular H-ras proto-oncogene.
- Trisomy of chromosome 7 occurs during premalignant clonal expansion, increasing mutant ras allele expression.
- p53 mutations and loss of heterozygosity are observed in some squamous carcinomas but not implicated in the transition to spindle cell tumors.
Conclusions:
- Mouse skin carcinogenesis models continue to yield critical insights into the genetic and biological events driving cancer progression.
- The transition to highly undifferentiated spindle cell tumors appears to be a recessive event.
- Specific genetic alterations, including H-ras activation and chromosomal changes, are stage-specific during multistage carcinogenesis.